Showing results (131-140 of 697) with videos related to
Sort By:
Pageof 70
Seminars in Thrombosis and Hemostasis|January 1, 1988
Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agentsD CollenJournal of the American College of Cardiology|November 1, 1987
Molecular mechanism of action of newer thrombolytic agentsD CollenThe American Journal of Cardiology|January 3, 1992
Designing thrombolytic agents: focus on safety and efficacyD CollenEuropean Journal of Biochemistry|October 1, 1976
Identification and some properties of a new fast-reacting plasmin inhibitor in human plasmaD CollenThrombosis and Haemostasis|May 25, 2001
Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thrombosesM Sanmarco, M C Alessi, J R Harle, et al.La Revue De Medecine Interne|May 24, 2003
[Heterozygous prothrombin gene mutation G20210A and associated diseases]B Granel, P-E Morange, J Serratrice, et al.Annales De Cardiologie Et D'Angeiologie|February 1, 1992
[Lipid indicators of vascular risk. A cross-sectional study of a group of coronary patients, a group of subjects with normal coronary angiography and a control group]M Heim, M Bory, J P Ardissone, et al.La Revue De Medecine Interne|January 1, 1990
[Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)]A Elias, L Milandre, G Lagrange, et al.Blood|November 1, 1995
The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiencyJ Duchemin, S Gandrille, D Borgel, et al.Journal of Thrombosis and Haemostasis : JTH|September 13, 2007
Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lungM Poggi, O Paulmyer-Lacroix, M Verdier, et al.Pageof 70